Validity and reliability of the Japanese version of LupusQoL: Assessment of disease-specific health-related quality of life in systemic lupus erythematosus

Abstract

Objective

To develop a Japanese version of LupusQoL (LupusQoL-JP) and assess its validity and reliability in patients with systemic lupus erythematosus (SLE).

Methods

This study consisted of two independent cross-sectional analyses using data from two different periods at our university clinic: 2011 (initial period, n = 266) and 2015–2018 (second period, n = 133). The English version of the LupusQoL was translated into Japanese and administered to Japanese patients with SLE, alongside other questionnaires, including the Medical Outcomes Study Short Form-36 (SF-36) and the 5-level EuroQoL 5-Dimensions Questionnaire (EQ-5D-5L). Physicians also completed measures such as the Systemic Lupus International Collaborating Clinics/American College of Rheumatology (ACR) Damage Index (SDI) and SLE Disease Activity Index 2000 (SLEDAI-2K), and assessed lupus low disease activity state (LLDAS) attainment.

Results

LupusQoL-JP showed acceptable internal consistency (Cronbach’s α > 0.8). All subscales, except for fatigue, demonstrated good test-retest reliability. The LupusQoL-JP and SF-36 scores were strongly correlated with comparable domains. The LupusQoL-JP subscale scores were moderately to strongly correlated with the EQ-5D-5L index values, while weakly correlated with the SDI and generally not correlated with age, disease duration, prednisolone dosage, or SLEDAI-2K. Some LupusQoL-JP domains were able to differentiate between the LLDAS and non-LLDAS groups.

Conclusion

LupusQoL-JP was successfully translated, adapted, and validated. It demonstrated good concurrent validity with comparable domains of the SF-36 and was independent of SLEDAI-2K. Patients with SLE in LLDAS were partly associated with better disease-specific health-related quality of life, as assessed by LupusQoL-JP.

Keywords

Systemic lupus erythematosus health-related quality of life outcome measures

Get full access to this article

View all access options for this article.

References

Golder

Kandane-Rathnayake

Hoi

, et al. Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study. Arthritis Res Ther 2017; 19: 62.

Gladman

Urowitz

Fortin

, et al. Systemic lupus international collaborating clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic lupus international collaborating clinics group. J Rheumatol 1996; 23: 1953–1955.

Strand

Gladman

Isenberg

, et al. Outcome measures to be used in clinical trials in systemic lupus erythematosus. J Rheumatol 1999; 26: 490–497.

Strand

Gladman

Isenberg

, et al. Endpoints: consensus recommendations from OMERACT IV. Outcome measures in rheumatology. Lupus 2000; 9: 322–327.

Yazdany

. Health-related quality of life measurement in adult systemic lupus erythematosus: lupus quality of life (LupusQoL), systemic lupus erythematosus-specific quality of life questionnaire (SLEQOL), and systemic lupus erythematosus quality of life questionnaire (L-QoL). Arthritis Care Res 2011; 63(Suppl 11): S413–S419.

Baba

Katsumata

Okamoto

, et al. Reliability of the SF-36 in Japanese patients with systemic lupus erythematosus and its associations with disease activity and damage: a two-consecutive year prospective study. Lupus 2018; 27: 407–416.

Yamashita

Katsumata

Konda

, et al. Comparisons between US norm-based two-component and Japanese norm-based three-component SF-36 summary scores in systemic lupus erythematosus patients. Mod Rheumatol 2023; 33: 517–524.

McElhone

Abbott

Shelmerdine

, et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum 2007; 57: 972–979.

McElhone

Castelino

Abbott

, et al. The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosus. J Rheumatol 2010; 37: 2273–2279.

10.

Jolly

Pickard

Wilke

, et al. Lupus-specific health outcome measure for US patients: the LupusQoL-US version. Ann Rheum Dis 2010; 69: 29–33.

11.

Jolly

Pickard

Mikolaitis

, et al. LupusQoL-US benchmarks for US patients with systemic lupus erythematosus. J Rheumatol 2010; 37: 1828–1833.

12.

Devilliers

Amoura

Besancenot

, et al. LupusQoL-FR is valid to assess quality of life in patients with systemic lupus erythematosus. Rheumatology 2012; 51: 1906–1915.

13.

Garcia-Carrasco

Mendoza-Pinto

Cardiel

, et al. Health related quality of life in Mexican women with systemic lupus erythematosus: a descriptive study using SF-36 and LupusQoL (C). Lupus 2012; 21: 1219–1224.

14.

Wang

Leng

, et al. Validity of LupusQoL-China for the assessment of health related quality of life in Chinese patients with systemic lupus erythematosus. PLoS One 2013; 8: e63795.

15.

Conti

Perricone

Reboldi

, et al. Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT. Lupus 2014; 23: 743–751.

16.

Hosseini

Bonakdar

Gholamrezaei

, et al. Linguistic validation of the LupusQoL for the assessment of quality of life in Iranian patients with systemic lupus erythematosus. Internet J Rheumatol 2014; 2014: 151530.

17.

Pamuk

Onat

Donmez

, et al. Validity and reliability of the Lupus QoL index in Turkish systemic lupus erythematosus patients. Lupus 2015; 24: 816–821.

18.

Machado Escobar

Yacuzzi

Martinez

, et al. Validation of an Argentine version of lupus quality of life questionnaire. Lupus 2016; 25: 1615–1622.

19.

Yilmaz-Oner

Oner

Dogukan

, et al. Health-related quality of life assessed by LupusQoL questionnaire and SF-36 in Turkish patients with systemic lupus erythematosus. Clin Rheumatol 2016; 35: 617–622.

20.

Carrion-Nessi

Marcano-Rojas

Freitas-DeNobrega

, et al. Validation of the LupusQoL in Venezuela: a specific measurement of quality of life in patients with systemic lupus erythematosus. Reumatol Clínica 2022; 18: 355–360.

21.

Faria

Alves

Oliveira

, et al. Validation of a disease-specific health-related quality of life measure in adult Portuguese patients with systemic lupus erythematosus: LupusQoL-PT. ARP Rheumatol 2022; 1: 210–218.

22.

Ahmad Pouzi

Shaharir

Mohd Tamil

, et al. Validation and the associated factors of the Malay version of systemic lupus erythematosus-specific health-related quality of life questionnaires (SLEQoL and LupusQoL). PLoS One 2023; 18: e0285461.

23.

Hochberg

. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.

24.

Petri

Orbai

Alarcon

, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64: 2677–2686.

25.

Bombardier

Gladman

Urowitz

, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 1992; 35: 630–640.

26.

Gladman

Ibanez

Urowitz

. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29: 288–291.

27.

Furie

Petri

Wallace

, et al. Novel evidence-based systemic lupus erythematosus responder index. Arthritis Rheum 2009; 61: 1143–1151.

28.

Gladman

Ginzler

Goldsmith

, et al. The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363–369.

29.

Golder

Kandane-Rathnayake

Huq

, et al. Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study. Lancet Rheumatol 2019; 1: e95–e102.

30.

Fukuhara

Bito

Green

, et al. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 1998; 51: 1037–1044.

31.

Ware

Jr Sherbourne

. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473–483.

32.

McHorney

Ware

Jr Raczek

. The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247–263.

33.

McHorney

Ware

Jr Lu

, et al. The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994; 32: 40–66.

34.

Fukuhara

Ware

Jr Kosinski

, et al. Psychometric and clinical tests of validity of the Japanese SF-36 health survey. J Clin Epidemiol 1998; 51: 1045–1053.

35.

Herdman

Gudex

Lloyd

, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011; 20: 1727–1736.

36.

Shiroiwa

Fukuda

Ikeda

, et al. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual Life Res 2016; 25: 707–719.

37.

Ikeda

Shiroiwa

Igarashi

, et al. Developing a Japanese version of the EQ-5D-5L value set. J Natl Inst Public Health 2015; 64: 47–55.

38.

Tavakol

Dennick

. Making sense of Cronbach’s alpha. Int J Med Educ 2011; 2: 53–55.

39.

Weir

. Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. J Strength Condit Res 2005; 19: 231–240.

40.

Landis

Koch

. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159–174.

41.

Torrance

Smith

Lee

, et al. Analysing the SF-36 in population-based research. A comparison of methods of statistical approaches using chronic pain as an example. J Eval Clin Pract 2009; 15: 328–334.

42.

Nantes

Strand

, et al. Comparison of the sensitivity to change of the 36-item short form health survey and the lupusqol using various definitions of minimal clinically important differences in patients with active systemic lupus erythematosus. Arthritis Care Res 2017; 70(1): 125–133.

43.

Devilliers

Amoura

Besancenot

, et al. Responsiveness of the 36-item short form health survey and the lupus quality of life questionnaire in SLE. Rheumatology 2015; 54: 940–949.

44.

McElhone

Abbott

Sutton

, et al. Sensitivity to change and minimal important differences of the LupusQoL in patients with systemic lupus erythematosus. Arthritis Care Res 2016; 68: 1505–1513.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.10 MB